PerCP/Cyanine5.5 Anti-Mouse CD161/NK1.1 Antibody[PK136]

Introducing the PERCP/CYANINE5.5 Anti-Mouse CD161/NK1.1 Antibody [PK136], a highly efficient and reliable immunological tool designed for advanced research applications. This antibody, with a product code of E-AB-F0987UJ, is available in a 100μg quantity, ensuring an ample supply for your experimental needs.

The PERCP/CYANINE5.5 Anti-Mouse CD161/NK1.1 Antibody [PK136] exhibits exceptional specificity and sensitivity, enabling precise detection and analysis of CD161/NK1.1 expression in mouse samples. Its superior performance is attributed to the utilization of cutting-edge technology and rigorous quality control measures during its production.

This antibody is specifically engineered to target CD161/NK1.1, a cell surface receptor predominantly expressed on natural killer (NK) cells and subsets of T cells. By binding to CD161/NK1.1, this antibody facilitates the identification and characterization of these cell populations, contributing to a deeper understanding of their functional roles in various biological processes.

The PERCP/CYANINE5.5 Anti-Mouse CD161/NK1.1 Antibody [PK136] demonstrates exceptional fluorescence properties, with the PERCP/CYANINE5.5 conjugate providing a bright and stable signal. This feature ensures accurate and reliable flow cytometric analysis, making it an invaluable tool for immunophenotyping studies and other related applications.

Furthermore, this antibody has been extensively validated and optimized for use in various experimental techniques, including flow cytometry, immunofluorescence, and immunohistochemistry. Its versatility allows for seamless integration into diverse research protocols, facilitating comprehensive investigations across multiple disciplines.

In summary, the PERCP/CYANINE5.5 Anti-Mouse CD161/NK1.1 Antibody [PK136] is a high-quality product that guarantees exceptional performance and reliability. With its advanced features and extensive validation, it serves as an indispensable tool for researchers seeking to unravel the complexities of CD161/NK1.1-expressing cell populations.